UK asbestos compensation ruling must now prompt meaningful R&D funding
This article was originally published in Clinica
The Scottish government has successfully defended a UK Supreme Court appeal by various insurance groups seeking to overturn legislation supporting the compensation of pleural plaques.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.